JANINE PAOLA CERILLA: Open Payments
NPI 1568244713 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 50 payments from 15 companies in 2025. Trend: 2023 $30 · 2024 $891 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $181 |
| CVRx, Inc. | 2 | $143 |
| SCPHARMACEUTICALS INC. | 1 | $120 |
| Merck Sharp & Dohme LLC | 7 | $116 |
| AstraZeneca Pharmaceuticals LP | 7 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $100 |
| Alnylam Pharmaceuticals Inc. | 5 | $81 |
| BridgeBio Pharma, Inc. | 4 | $76 |
| AtriCure, Inc. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
Products named: Cresemba, Barostim Neo System, FUROSCIX, VERQUVO, Attruby, JARDIANCE, AMVUTTRA, ATRICLIP LAA EXCLUSION SYSTEM.
Industry payments across NJ — which companies pay providers there.
